Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its investor relation team will participate in the following upcoming investor conference:
Conference Portzamparc – Evenement Corporate Access, Paris (in-person event)
Event Date: June 30, 2022
| Press Release in English | 141.32 KB |
| Communiqué en français | 142.89 KB |